Login
Cart
Support
Search
Search
Search
DDW 2024 On Demand
Fernando Alarid Escudero
Appearances
View Grid
CMS COVERAGE DECISION: IMPLICATIONS FOR COST-EFFECITVENESS OF BLOOD-BASED COLORECTAL CANCER SCREENING
Date
May 20, 2024
A blood-based colorectal cancer (CRC) screening test may increase screening participation. However, blood-based screening tests may be less effective than current guideline-endorsed options…
Presenter
Rosita van den Puttelaar
Speakers
Pedro Nascimento de Lima
Amy Knudsen
Carolyn Rutter
Fred Hutchinson Cancer Center
Karen Kuntz
Lucie De Jonge
Fernando Alarid Escudero
David Lieberman
Oregon Health and Science University
Ann Zauber
Memorial Sloan Kettering Cancer Center Department of Epidemiology & Biostatistics
Anne Hahn
John Inadomi
University of Utah School of Medicine
Iris Lansdorp-Vogelaar
Erasmus MC
CHARACTERISTICS OF A COST-EFFECTIVE BLOOD TEST FOR COLORECTAL CANCER SCREENING
Date
May 20, 2024
Blood-based biomarker tests have been developed as a non-invasive colorectal cancer (CRC) screening method to triage patients to colonoscopy…
Presenter
Pedro Nascimento de Lima
Speakers
Rosita van den Puttelaar
Amy Knudsen
Anne Hahn
Nicholson Collier
Jonathan Ozik
Fernando Alarid Escudero
Karen Kuntz
Ann Zauber
Memorial Sloan Kettering Cancer Center Department of Epidemiology & Biostatistics
John Inadomi
University of Utah School of Medicine
Iris Lansdorp-Vogelaar
Erasmus MC
Carolyn Rutter
Fred Hutchinson Cancer Center